Current Insights into the Role of BRAF Inhibitors in Treatment of Melanoma.

Singh, Ankit Kumar; Kumar, Adarsh; Thareja, Suresh; Kumar, Pradeep

Singh, Ankit Kumar; Kumar, Adarsh; Thareja, Suresh; Kumar, Pradeep.

Singh AK; Department of Pharmaceutical Sciences and Natural Products, Central University of Punjab 151401, Bathinda, India.
Kumar A; Department of Pharmaceutical Sciences and Natural Products, Central University of Punjab 151401, Bathinda, India.
Thareja S; Department of Pharmaceutical Sciences and Natural Products, Central University of Punjab 151401, Bathinda, India.
Kumar P; Department of Pharmaceutical Sciences and Natural Products, Central University of Punjab 151401, Bathinda, India.

Anticancer Agents Med Chem ; 23(3): 278-297, 2023.

Article en En | MEDLINE | ID: mdl-35761499

Asunto(s)

Melanoma; Neoplasias Cutáneas; Humanos; Proteínas Proto-Oncogénicas B-raf/genética; Melanoma/tratamiento farmacológico; Melanoma/genética; Inhibidores de Proteínas Quinasas/farmacología; Inhibidores de Proteínas Quinasas/uso terapéutico; Proteínas Quinasas Activadas por Mitógenos; Quinasas de Proteína Quinasa Activadas por Mitógenos

Palabras clave

BRAF; DFG motif; MAPK; Melanoma; RAF; RAS; αC-helix

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Melanoma Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Search on Google